The Class I recall includes units distributed from September 2020 to August 2021.

Researchers turned to recent Medicare data to learn more about ongoing trends in interventional cardiology. 

TTE, researchers wrote, was "as good as abdominal ultrasound" when it came to screening for AAA. 

The mortality rate for COVID-19 patients was nearly twice as high if they had a history of peripheral artery disease, researchers found. 

“Thrombosis interrupts and delays venous therapy, increases cost of care and can lead to significant adverse patient outcomes," researchers said. 

The findings, based on Medicare data, were presented at VIVA21 in Las Vegas.

The new study, published in Stroke, included data related to aspiration and stent retriever thrombectomy.

In-hospital outcomes were similar, but the difference between the two options became clear as time went on. 

The trial will enroll a total of 250 CAD patients. 

The analysis also focused on outcomes related to heart attacks, definite stent thrombosis and more. 

The study's authors hope their work can help with the development of new interventions that target this issue.